{"id":1583,"date":"2024-09-03T20:25:43","date_gmt":"2024-09-03T14:55:43","guid":{"rendered":"https:\/\/gaainfo.com\/?p=1583"},"modified":"2024-08-23T16:45:47","modified_gmt":"2024-08-23T11:15:47","slug":"wockhardt-share-price-target","status":"publish","type":"post","link":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/","title":{"rendered":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"},"content":{"rendered":"<p>Wockhardt is an overall drug and biotechnology organization that produces expendable dose structures, injectable medications, biopharmaceutical drugs, oral medications, topically regulated medications(ointments or creams). Indian pharmaceutical and healthcare company Wockhardt Pharma Limited was established in 1967. Since that time we have been in the bleeding edge of the business&#8217; advancement; a way that has been portrayed by improvement and foundation of itself as a global forerunner in the area.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2024-2030\"><\/span>Wockhardt Share Price Target 2024-2030<span class=\"ez-toc-section-end\"><\/span><\/h2><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_69_1 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Main Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #63d611;color:#63d611\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #63d611;color:#63d611\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2024-2030\" title=\"Wockhardt Share Price Target 2024-2030\">Wockhardt Share Price Target 2024-2030<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_Today_Update\" title=\"Wockhardt Share Price Target Today Update\">Wockhardt Share Price Target Today Update<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#What_is_Wockhardt\" title=\"What is Wockhardt?\">What is Wockhardt?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Business_Profile\" title=\"Wockhardt Business Profile\">Wockhardt Business Profile<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Global_Presence\" title=\"Global Presence\">Global Presence<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Vaccine_Manufacturing\" title=\"Vaccine Manufacturing\">Vaccine Manufacturing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Manufacturing_Capabilities\" title=\"Manufacturing Capabilities\">Manufacturing Capabilities<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Strategic_Partnerships\" title=\"Strategic Partnerships\">Strategic Partnerships<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#WOCKPHARMA_Hospitals\" title=\"WOCKPHARMA Hospitals\">WOCKPHARMA Hospitals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Fundamentals_Quarterly_Results\" title=\"Wockhardt Share Fundamentals &amp; Quarterly Results\">Wockhardt Share Fundamentals &amp; Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Quarterly_Results\" title=\"Wockhardt Quarterly Results\">Wockhardt Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#WOCKPHARMA_CAGR_Report\" title=\"WOCKPHARMA CAGR Report\">WOCKPHARMA CAGR Report<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Shareholding_Pattern\" title=\"Wockhardt Shareholding Pattern\">Wockhardt Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2024-2030_Forecast\" title=\"Wockhardt Share Price Target 2024-2030 Forecast\">Wockhardt Share Price Target 2024-2030 Forecast<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#WOCKPHARMA_Share_Price_Target_2025\" title=\"WOCKPHARMA Share Price Target 2025\">WOCKPHARMA Share Price Target 2025<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#WOCKPHARMA_Share_Price_Target_2026\" title=\"WOCKPHARMA Share Price Target 2026\">WOCKPHARMA Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2027\" title=\"Wockhardt Share Price Target 2027\">Wockhardt Share Price Target 2027<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2028\" title=\"Wockhardt Share Price Target 2028\">Wockhardt Share Price Target 2028<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2029\" title=\"Wockhardt Share Price Target 2029\">Wockhardt Share Price Target 2029<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Wockhardt_Share_Price_Target_2030\" title=\"Wockhardt Share Price Target 2030\">Wockhardt Share Price Target 2030<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Points_Before_Investing_in_Wockhardt_Stock\" title=\"Points Before Investing in Wockhardt Stock\">Points Before Investing in Wockhardt Stock<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#Final_Words\" title=\"Final Words\">Final Words<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p>Over five decades ago, WOCKPHARMA was founded. In point of fact, this global reach accounts for approximately 67 percent of annual revenue. Wockhardt Pharma Restricted is an Indian medical care and drug endeavor, established in 1967. The multinational corporation operates in 30 nations and six continents around the world. On every continent and in thirty countries, multinational corporations operate.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_Today_Update\"><\/span>Wockhardt Share Price Target Today Update<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>As of right now, at 4:56 p.m. on Wednesday, the Wockhardt Pharma share price has dropped by 3.94 percent. When the National Stock Exchange opened for the day, the stock started at Rs 578 per share. Anyway NSE: WOCKPHARMA proceeded with its slump direction since the 1 Mrach high of Rs 620 for every offer.<\/li>\n<li>According to reports, on February 26, 2024, the healthcare and pharmaceutical company Wockhardt would raise Rs 400 crores on a priority basis and offer the QIP at an average price over the previous ten days.<\/li>\n<li>Wockhardt Pharma reported several years back about its coordinated effort with the UK based Serum Life Sciences. The goal of this partnership was to produce 150 million different vaccines in North Wales.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Wockhardt\"><\/span>What is Wockhardt?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Wockhardt Pharma Share Price is an Indian-based medical services and drug organization that was laid out in 1967. It operates in 30 nations and six continents worldwide. The financial results for the company&#8217;s December quarter suggest that the stock will probably rise in the coming months. Nevertheless, it is essential to note that the company&#8217;s financial results for 2023 are unfavorable. The factors that influence Wockhardt Pharma&#8217;s NSE share price and the company&#8217;s share price target for 2025 and beyond will be discussed in this article.<\/p>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/tata-investment-share-price-target\/\"><u>Tata Investment Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/mazagon-dock-share-price-target\/\"><u>Mazagon Dock Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Business_Profile\"><\/span>Wockhardt Business Profile<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company is present in both the retail and hospital channels and is one of the three major Indian generic companies in the UK. It is also the sixth largest supplier of generics in Ireland. With a market share of 21.7 percent, its Wepox trademark is the bioequivalent of erythropoetin, while its Methylcobalamin trademark is the most popular.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Global_Presence\"><\/span>Global Presence<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company operates fully in France, the United States, India, and the United Kingdom. It sells its other products in Russia, Brazil, Mexico, Vietnam, the Philippines, Nigeria, Kenya, Ghana, Tanzania, Nepal, Uganda, Mauritius, Myanmar, Sri Lanka, Lebanon, and Kuwait, among other emerging markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Vaccine_Manufacturing\"><\/span>Vaccine Manufacturing<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The UK Government and The Company came to an agreement to fill and finish COVID-19 vaccines that were made at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales. The agreement stipulates that the company will keep its production capacity in order to provide the UK Government with a variety of vaccines, including AZD122, which was co-invented by Oxford University and licensed by AstraZeneca.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Manufacturing_Capabilities\"><\/span>Manufacturing Capabilities<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>By establishing an inter-calibrated network of instruments, the company has established a multi-technology capacity that encompasses the production of all dose forms, from sterile injections to lyophilized products. The Food and Drug Administration of the United States, the European Medicine Agency, and the British Medicine and Health Product Regulatory Agency are the three organizations that oversee the 14 dynamically operating factories that are located in various nations around the world, specifically in India, Britain, and the United States. Each of these factories is supervised by highly skilled craftsmen on a daily basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Strategic_Partnerships\"><\/span>Strategic Partnerships<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Wockhardt and Wockhardt Bio AG, a subsidiary of the company and Jiangxi Jemincare Group Company Limited in China, collaborate on the production of an innovative antibiotic known as Nafithromycin, which Wockhardt owns a patent for. In response, CP Pharmaceuticals Limited, a subsidiary of the Company, and Serum Life Sciences UK have begun a global vaccine program with 150 million doses per year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"WOCKPHARMA_Hospitals\"><\/span>WOCKPHARMA Hospitals<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In various regions of Gujarat and Maharashtra state, Wockhardt Hospitals owns six super-specialty hospitals. By providing high-quality healthcare and conducting cutting-edge research in the regenerative medicine field, including Stem Cells and Growth Factor Concentrate (GFC) Therapy for Hair Regrowth, Aesthetics, Orthopaedics, and Chronic Wound Healing, the hospital set the standard for clinical excellence.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Fundamentals_Quarterly_Results\"><\/span>Wockhardt Share Fundamentals &amp; Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 1395px;\" width=\"456\">\n<tbody>\n<tr>\n<td>Terms<\/td>\n<td>Value<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>\u20b9 8,238 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Current Price<\/td>\n<td>\u20b9 537<\/td>\n<\/tr>\n<tr>\n<td>High \/ Low<\/td>\n<td>\u20b9 630 \/ 167<\/td>\n<\/tr>\n<tr>\n<td><strong>Stock P\/E<\/strong><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>Book Value<\/td>\n<td>\u20b9 219<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.00 %<\/td>\n<\/tr>\n<tr>\n<td>ROCE<\/td>\n<td>-1.70 %<\/td>\n<\/tr>\n<tr>\n<td>ROE<\/td>\n<td>-13.4 %<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>\u20b9 5.00<\/td>\n<\/tr>\n<tr>\n<td>Debt to equity<\/td>\n<td>0.70<\/td>\n<\/tr>\n<tr>\n<td>Debt Capacity<\/td>\n<td>-0.14<\/td>\n<\/tr>\n<tr>\n<td>Debt preceding year<\/td>\n<td>\u20b9 2,184 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Debt<\/td>\n<td>\u20b9 2,356 Cr.<\/td>\n<\/tr>\n<tr>\n<td>Reserves<\/td>\n<td>\u20b9 3,282 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EPS<\/td>\n<td>\u20b9 -30.2<\/td>\n<\/tr>\n<tr>\n<td>EPS last year<\/td>\n<td>\u20b9 -30.2<\/td>\n<\/tr>\n<tr>\n<td>Pledged percentage<\/td>\n<td>52.9 %<\/td>\n<\/tr>\n<tr>\n<td>FCF Prev Ann<\/td>\n<td>\u20b9 23.0 Cr.<\/td>\n<\/tr>\n<tr>\n<td>EVEBITDA<\/td>\n<td>82.5<\/td>\n<\/tr>\n<tr>\n<td>Industry PE<\/td>\n<td>30.7<\/td>\n<\/tr>\n<tr>\n<td><strong>PEG Ratio<\/strong><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>Piotroski score<\/td>\n<td>3.00<\/td>\n<\/tr>\n<tr>\n<td>Earnings yield<\/td>\n<td>-1.01 %<\/td>\n<\/tr>\n<tr>\n<td>Sales growth 5Years<\/td>\n<td>-4.73 %<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/exide-share-price-target\/\"><u>Exide Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/icici-bank-share-price-target\/\"><u>ICICI Bank Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Quarterly_Results\"><\/span>Wockhardt Quarterly Results<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td><\/td>\n<td>Dec 2021<\/td>\n<td>Mar 2022<\/td>\n<td>Jun 2022<\/td>\n<td>Sep 2022<\/td>\n<td>Dec 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Jun 2023<\/td>\n<td>Sep 2023<\/td>\n<td>Dec 2023<\/td>\n<td>Mar 2024<\/td>\n<\/tr>\n<tr>\n<td>Sales +<\/td>\n<td>854<\/td>\n<td>655<\/td>\n<td>595<\/td>\n<td>679<\/td>\n<td>699<\/td>\n<td>678<\/td>\n<td>644<\/td>\n<td>753<\/td>\n<td>701<\/td>\n<td>700<\/td>\n<\/tr>\n<tr>\n<td>Expenses +<\/td>\n<td>742<\/td>\n<td>688<\/td>\n<td>611<\/td>\n<td>636<\/td>\n<td>654<\/td>\n<td>675<\/td>\n<td>628<\/td>\n<td>681<\/td>\n<td>664<\/td>\n<td>803<\/td>\n<\/tr>\n<tr>\n<td>Operating Profit<\/td>\n<td>112<\/td>\n<td>-33<\/td>\n<td>-16<\/td>\n<td>43<\/td>\n<td>45<\/td>\n<td>3<\/td>\n<td>16<\/td>\n<td>72<\/td>\n<td>37<\/td>\n<td>-103<\/td>\n<\/tr>\n<tr>\n<td>OPM %<\/td>\n<td>13%<\/td>\n<td>-5%<\/td>\n<td>-3%<\/td>\n<td>6%<\/td>\n<td>6%<\/td>\n<td>0%<\/td>\n<td>2%<\/td>\n<td>10%<\/td>\n<td>5%<\/td>\n<td>-15%<\/td>\n<\/tr>\n<tr>\n<td>Other Income +<\/td>\n<td>2<\/td>\n<td>-169<\/td>\n<td>57<\/td>\n<td>-138<\/td>\n<td>-1<\/td>\n<td>-64<\/td>\n<td>0<\/td>\n<td>24<\/td>\n<td>8<\/td>\n<td>54<\/td>\n<\/tr>\n<tr>\n<td>Interest<\/td>\n<td>80<\/td>\n<td>86<\/td>\n<td>73<\/td>\n<td>70<\/td>\n<td>83<\/td>\n<td>76<\/td>\n<td>79<\/td>\n<td>76<\/td>\n<td>77<\/td>\n<td>73<\/td>\n<\/tr>\n<tr>\n<td>Depreciation<\/td>\n<td>62<\/td>\n<td>59<\/td>\n<td>64<\/td>\n<td>65<\/td>\n<td>66<\/td>\n<td>56<\/td>\n<td>55<\/td>\n<td>55<\/td>\n<td>55<\/td>\n<td>58<\/td>\n<\/tr>\n<tr>\n<td>Profit before tax<\/td>\n<td>-28<\/td>\n<td>-347<\/td>\n<td>-96<\/td>\n<td>-230<\/td>\n<td>-105<\/td>\n<td>-193<\/td>\n<td>-118<\/td>\n<td>-35<\/td>\n<td>-87<\/td>\n<td>-180<\/td>\n<\/tr>\n<tr>\n<td>Tax %<\/td>\n<td>107%<\/td>\n<td>10%<\/td>\n<td>22%<\/td>\n<td>10%<\/td>\n<td>3%<\/td>\n<td>-23%<\/td>\n<td>-15%<\/td>\n<td>-109%<\/td>\n<td>1%<\/td>\n<td>2%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit +<\/td>\n<td>2<\/td>\n<td>-311<\/td>\n<td>-75<\/td>\n<td>-207<\/td>\n<td>-102<\/td>\n<td>-237<\/td>\n<td>-136<\/td>\n<td>-73<\/td>\n<td>-86<\/td>\n<td>-177<\/td>\n<\/tr>\n<tr>\n<td>EPS in Rs<\/td>\n<td>-0.49<\/td>\n<td>-17.91<\/td>\n<td>-4.65<\/td>\n<td>-13.12<\/td>\n<td>-6.66<\/td>\n<td>-14.44<\/td>\n<td>-9.30<\/td>\n<td>-5.34<\/td>\n<td>-5.76<\/td>\n<td>-11.02<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"WOCKPHARMA_CAGR_Report\"><\/span>WOCKPHARMA CAGR Report<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 287px;\" width=\"631\">\n<tbody>\n<tr>\n<td><\/td>\n<td>10 Years<\/td>\n<td>5 Years<\/td>\n<td>3 Years<\/td>\n<td>Last Year (TTM)<\/td>\n<\/tr>\n<tr>\n<td>Compounded Sales Growth<\/td>\n<td>-5%<\/td>\n<td>-5%<\/td>\n<td>1%<\/td>\n<td>6%<\/td>\n<\/tr>\n<tr>\n<td>Compounded Profit Growth<\/td>\n<td>-51%<\/td>\n<td><\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>Stock Price CAGR<\/td>\n<td>0%<\/td>\n<td>8%<\/td>\n<td>-2%<\/td>\n<td>217%<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>-1%<\/td>\n<td>0%<\/td>\n<td>-8%<\/td>\n<td>-13%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Shareholding_Pattern\"><\/span>Wockhardt Shareholding Pattern<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Shareholder Type<\/td>\n<td>Mar 2017<\/td>\n<td>Mar 2018<\/td>\n<td>Mar 2019<\/td>\n<td>Mar 2020<\/td>\n<td>Mar 2021<\/td>\n<td>Mar 2022<\/td>\n<td>Mar 2023<\/td>\n<td>Mar 2024<\/td>\n<\/tr>\n<tr>\n<td>Promoters +<\/td>\n<td>74.25%<\/td>\n<td>74.11%<\/td>\n<td>74.07%<\/td>\n<td>72.13%<\/td>\n<td>72.12%<\/td>\n<td>67.13%<\/td>\n<td>59.31%<\/td>\n<td>51.60%<\/td>\n<\/tr>\n<tr>\n<td>FIIs +<\/td>\n<td>4.55%<\/td>\n<td>5.45%<\/td>\n<td>4.74%<\/td>\n<td>4.85%<\/td>\n<td>3.10%<\/td>\n<td>2.89%<\/td>\n<td>2.78%<\/td>\n<td>5.49%<\/td>\n<\/tr>\n<tr>\n<td>DIIs +<\/td>\n<td>2.71%<\/td>\n<td>4.99%<\/td>\n<td>2.55%<\/td>\n<td>0.24%<\/td>\n<td>0.09%<\/td>\n<td>0.09%<\/td>\n<td>0.22%<\/td>\n<td>4.82%<\/td>\n<\/tr>\n<tr>\n<td>Government +<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.00%<\/td>\n<td>0.01%<\/td>\n<\/tr>\n<tr>\n<td>Public +<\/td>\n<td>18.49%<\/td>\n<td>15.45%<\/td>\n<td>18.64%<\/td>\n<td>22.78%<\/td>\n<td>24.69%<\/td>\n<td>29.89%<\/td>\n<td>37.70%<\/td>\n<td>38.06%<\/td>\n<\/tr>\n<tr>\n<td>No. of Shareholders<\/td>\n<td>1,24,403<\/td>\n<td>99,736<\/td>\n<td>1,14,338<\/td>\n<td>1,17,324<\/td>\n<td>1,25,488<\/td>\n<td>1,72,460<\/td>\n<td>1,82,493<\/td>\n<td>1,46,138<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2024-2030_Forecast\"><\/span>Wockhardt Share Price Target 2024-2030 Forecast<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 452px;\" width=\"522\">\n<tbody>\n<tr>\n<td>Year<\/td>\n<td>Initial Target<\/td>\n<td>Mid-Year Target<\/td>\n<td>Year-End Target<\/td>\n<\/tr>\n<tr>\n<td>2024<\/td>\n<td>\u20b9529.44<\/td>\n<td>\u20b9660.8<\/td>\n<td>\u20b9739.61<\/td>\n<\/tr>\n<tr>\n<td>2025<\/td>\n<td>\u20b9754<\/td>\n<td>\u20b9709<\/td>\n<td>\u20b9846<\/td>\n<\/tr>\n<tr>\n<td>2026<\/td>\n<td>\u20b9863<\/td>\n<td>\u20b9811<\/td>\n<td>\u20b9968<\/td>\n<\/tr>\n<tr>\n<td>2027<\/td>\n<td>\u20b9987<\/td>\n<td>\u20b9928<\/td>\n<td>\u20b91108<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>\u20b91130<\/td>\n<td>\u20b91062<\/td>\n<td>\u20b91267<\/td>\n<\/tr>\n<tr>\n<td>2029<\/td>\n<td>\u20b91292<\/td>\n<td>\u20b91214<\/td>\n<td>\u20b91450<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>\u20b91479<\/td>\n<td>\u20b91390<\/td>\n<td>\u20b91660<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"WOCKPHARMA_Share_Price_Target_2025\"><\/span>WOCKPHARMA Share Price Target 2025<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 732px;\" width=\"527\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b9754<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b9769<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b9784<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b9758<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b9733<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b9709<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b9737<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b9766<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b9797<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b9813<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b9829<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b9846<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"WOCKPHARMA_Share_Price_Target_2026\"><\/span>WOCKPHARMA Share Price Target 2026<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 712px;\" width=\"470\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b9863<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b9880<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b9898<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b9868<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b9839<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b9811<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b9843<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b9877<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b9912<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b9930<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b9949<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b9968<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2027\"><\/span>Wockhardt Share Price Target 2027<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 741px;\" width=\"492\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b9987<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b91007<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b91027<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b9993<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b9960<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b9928<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b9965<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b91004<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b91044<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b91065<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b91086<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b91108<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2028\"><\/span>Wockhardt Share Price Target 2028<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 739px;\" width=\"491\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b91130<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b91153<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b91176<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b91137<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b91099<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b91062<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b91104<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b91148<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b91194<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b91218<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b91242<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b91267<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Read More:-<\/strong><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/hal-share-price-target\/\"><u>HAL Share Price Target<\/u><\/a><\/p>\n<p><a href=\"https:\/\/gaainfo.com\/vedanta-share-price-target\/\"><u>Vedanta Share Price Target<\/u><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2029\"><\/span>Wockhardt Share Price Target 2029<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 711px;\" width=\"478\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b91292<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b91318<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b91344<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b91299<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b91256<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b91214<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b91263<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b91314<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b91367<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b91394<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b91422<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b91450<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Wockhardt_Share_Price_Target_2030\"><\/span>Wockhardt Share Price Target 2030<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table style=\"height: 707px;\" width=\"445\">\n<tbody>\n<tr>\n<td>Month<\/td>\n<td>Target<\/td>\n<\/tr>\n<tr>\n<td>January<\/td>\n<td>\u20b91479<\/td>\n<\/tr>\n<tr>\n<td>February<\/td>\n<td>\u20b91509<\/td>\n<\/tr>\n<tr>\n<td>March<\/td>\n<td>\u20b91539<\/td>\n<\/tr>\n<tr>\n<td>April<\/td>\n<td>\u20b91488<\/td>\n<\/tr>\n<tr>\n<td>May<\/td>\n<td>\u20b91438<\/td>\n<\/tr>\n<tr>\n<td>June<\/td>\n<td>\u20b91390<\/td>\n<\/tr>\n<tr>\n<td>July<\/td>\n<td>\u20b91446<\/td>\n<\/tr>\n<tr>\n<td>August<\/td>\n<td>\u20b91504<\/td>\n<\/tr>\n<tr>\n<td>September<\/td>\n<td>\u20b91564<\/td>\n<\/tr>\n<tr>\n<td>October<\/td>\n<td>\u20b91595<\/td>\n<\/tr>\n<tr>\n<td>November<\/td>\n<td>\u20b91627<\/td>\n<\/tr>\n<tr>\n<td>December<\/td>\n<td>\u20b91660<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Points_Before_Investing_in_Wockhardt_Stock\"><\/span>Points Before Investing in Wockhardt Stock<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>In a CNBCTV18 report, a Market Expert had predicted a &#8220;Buy&#8221; call for the Wockhardt Share. The Wockhardt Pharma Share Price Target was evaluated by Mr. Shrikant Chouhan of Kotak Securities at Rs 500 in February 2024. The Kotak Securities analyst stated that the WOCKPHARMA NSE stop loss is Rs 450.<\/li>\n<li>In December 2023, Wockhardt Pharma&#8217;s net sales increased only marginally year over year. Drug Venture &#8221;Wockhardt&#8221; net deals expanded by simply 2.13% to Rs 288 crores (Dec 2023) from Rs 282 crores (Dec 2022).<\/li>\n<li>In the fiscal year 2023, the healthcare and pharmaceutical company &#8220;Wockhardt Limited&#8221; based in India will see a decline in revenue of -17.93 percent (YoY) to Rs 26.51 billion.<\/li>\n<li>From FY2022 to FY2023, the Wockhardt Pharma company has struggled to maintain its negative financial results year over year. However, WOCKPHARMA: NSE was able to generate positive financial results for its investors during the December quarter of 2023.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Final_Words\"><\/span>Final Words<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company&#8217;s financial results for the December quarter and the share price of Wockhardt suggest that the stock will perform better in the coming months. However, Wockhardt Pharma Limited&#8217;s overall negative financial results in 2023 must be remembered. We will talk about the different elements that impact the Public Stock Trade share cost of Wockhardt Pharma and the Wockhardt Offer Value Focus through 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wockhardt is an overall drug and biotechnology organization that produces expendable dose structures, injectable medications, biopharmaceutical drugs, oral medications, topically regulated medications(ointments or creams). Indian pharmaceutical and healthcare company Wockhardt Pharma Limited was established in 1967. Since that time we have been in the bleeding edge of the business&#8217; advancement; a way that has been &#8230; <a title=\"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\" class=\"read-more\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\" aria-label=\"Read more about Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\">Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":1606,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1583","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stocks"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &amp; Quarterly Results - Gaainfo\" \/>\n<meta property=\"og:description\" content=\"Wockhardt is an overall drug and biotechnology organization that produces expendable dose structures, injectable medications, biopharmaceutical drugs, oral medications, topically regulated medications(ointments or creams). Indian pharmaceutical and healthcare company Wockhardt Pharma Limited was established in 1967. Since that time we have been in the bleeding edge of the business&#8217; advancement; a way that has been ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\" \/>\n<meta property=\"og:site_name\" content=\"Gaainfo\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-03T14:55:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-23T11:15:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oliver\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oliver\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\"},\"author\":{\"name\":\"Oliver\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\"},\"headline\":\"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\",\"datePublished\":\"2024-09-03T14:55:43+00:00\",\"dateModified\":\"2024-08-23T11:15:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\"},\"wordCount\":1295,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg\",\"articleSection\":[\"Stocks\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\",\"url\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\",\"name\":\"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo\",\"isPartOf\":{\"@id\":\"https:\/\/gaainfo.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg\",\"datePublished\":\"2024-09-03T14:55:43+00:00\",\"dateModified\":\"2024-08-23T11:15:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg\",\"width\":800,\"height\":800,\"caption\":\"Wockhardt Share Price Target Today Update\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/gaainfo.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/gaainfo.com\/#website\",\"url\":\"https:\/\/gaainfo.com\/\",\"name\":\"Gaainfo\",\"description\":\"Tech, Result, Sports, Live News\",\"publisher\":{\"@id\":\"https:\/\/gaainfo.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/gaainfo.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/gaainfo.com\/#organization\",\"name\":\"Gaainfo\",\"url\":\"https:\/\/gaainfo.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"contentUrl\":\"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png\",\"width\":387,\"height\":320,\"caption\":\"Gaainfo\"},\"image\":{\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae\",\"name\":\"Oliver\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/gaainfo.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g\",\"caption\":\"Oliver\"},\"url\":\"https:\/\/gaainfo.com\/author\/oliver\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/","og_locale":"en_US","og_type":"article","og_title":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","og_description":"Wockhardt is an overall drug and biotechnology organization that produces expendable dose structures, injectable medications, biopharmaceutical drugs, oral medications, topically regulated medications(ointments or creams). Indian pharmaceutical and healthcare company Wockhardt Pharma Limited was established in 1967. Since that time we have been in the bleeding edge of the business&#8217; advancement; a way that has been ... Read more","og_url":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/","og_site_name":"Gaainfo","article_published_time":"2024-09-03T14:55:43+00:00","article_modified_time":"2024-08-23T11:15:47+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","type":"image\/jpeg"}],"author":"Oliver","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Oliver","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#article","isPartOf":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/"},"author":{"name":"Oliver","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae"},"headline":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results","datePublished":"2024-09-03T14:55:43+00:00","dateModified":"2024-08-23T11:15:47+00:00","mainEntityOfPage":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/"},"wordCount":1295,"commentCount":0,"publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"image":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","articleSection":["Stocks"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gaainfo.com\/wockhardt-share-price-target\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/","url":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/","name":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals & Quarterly Results - Gaainfo","isPartOf":{"@id":"https:\/\/gaainfo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage"},"image":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage"},"thumbnailUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","datePublished":"2024-09-03T14:55:43+00:00","dateModified":"2024-08-23T11:15:47+00:00","breadcrumb":{"@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gaainfo.com\/wockhardt-share-price-target\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#primaryimage","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","width":800,"height":800,"caption":"Wockhardt Share Price Target Today Update"},{"@type":"BreadcrumbList","@id":"https:\/\/gaainfo.com\/wockhardt-share-price-target\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gaainfo.com\/"},{"@type":"ListItem","position":2,"name":"Wockhardt Share Price Target 2024-2030 Today Update, Business Profile, Fundamentals &#038; Quarterly Results"}]},{"@type":"WebSite","@id":"https:\/\/gaainfo.com\/#website","url":"https:\/\/gaainfo.com\/","name":"Gaainfo","description":"Tech, Result, Sports, Live News","publisher":{"@id":"https:\/\/gaainfo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gaainfo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/gaainfo.com\/#organization","name":"Gaainfo","url":"https:\/\/gaainfo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/","url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","contentUrl":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/cropped-Gaainfo-Logo.png","width":387,"height":320,"caption":"Gaainfo"},"image":{"@id":"https:\/\/gaainfo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/8db315b428de933a19815c7768965eae","name":"Oliver","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/gaainfo.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fde348eb89f6a71493cd2d956aa938da?s=96&d=mm&r=g","caption":"Oliver"},"url":"https:\/\/gaainfo.com\/author\/oliver\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/gaainfo.com\/wp-content\/uploads\/2024\/08\/Wockhardt-Share-Price-Target-Today-Update.jpg","_links":{"self":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1583"}],"collection":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/comments?post=1583"}],"version-history":[{"count":5,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1583\/revisions"}],"predecessor-version":[{"id":1608,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/posts\/1583\/revisions\/1608"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media\/1606"}],"wp:attachment":[{"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/media?parent=1583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/categories?post=1583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gaainfo.com\/wp-json\/wp\/v2\/tags?post=1583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}